Skip to content

The effect of anrikefon injection on postoperative fatigue syndrome in patients undergoing thoracoscopic pneumonectomy: a randomized controlled trial

The effect of anrikefon injection on postoperative fatigue syndrome in patients undergoing thoracoscopic pneumonectomy: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600132317
Enrollment
Unknown
Registered
2026-09-11
Start date
2026-09-17
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who have undergone lung resection surgery

Interventions

control group:Sufentanil

Sponsors

The first affiliated hospital of anhui medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are scheduled to undergo thoracoscopic partial pneumonectomy under general anesthesia; 2. Age: 18 to 75 years old, gender not limited; 3. American Society of Anesthesiologists (ASA) grade I-III; 4. 18 kg/m^2 <= body mass index (BMI) <= 40 kg/m^2; 5. Be aware of and agree to participate in the trial and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1.Those with a history of allergy to opioids or local anesthetics, or those allergic to intraoperative anesthetics as stipulated in the protocol; 2.Patients with chronic preoperative pain or those who have been using analgesic drugs for a long time; 3.Severe heart (NYHA grade III or IV), liver (Child-Pugh 10 to 15 points), kidney (renal replacement therapy), hematopoietic system (leukemia) diseases; 4.Those who have mental system diseases or language disorders before the operation, or other factors that cause communication difficulties and prevent them from completing the scale assessment; 5.Refuse to participate in or have participated in other clinical studies within the past three months.

Design outcomes

Primary

MeasureTime frame
Postoperative fatigue syndrome;

Secondary

MeasureTime frame
Postoperative pain;Postoperative recovery quality;

Countries

China

Contacts

Public ContactChen Lijian

The first affiliated hospital of anhui medical university

chenlijian77@126.com+86 13966699467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026